{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:31:45Z","timestamp":1783690305447,"version":"3.55.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1097\/mjt.0000000000000024","type":"journal-article","created":{"date-parts":[[2014,1,22]],"date-time":"2014-01-22T13:06:09Z","timestamp":1390395969000},"page":"e321-e323","source":"Crossref","is-referenced-by-count":12,"title":["Gemcitabine-Induced Pseudocellulitis in a Patient With Recurrent Lymphedema"],"prefix":"10.1097","volume":"23","author":[{"given":"Susanna","family":"Curtis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasim","family":"Gucalp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-54-20210202","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00001813-200001000-00003","article-title":". Time- and dose-limiting erysipeloid rash confined to areas of lymphedema following treatment with gemcitabinea report of three cases.","volume":"11","author":"Brandes","year":"2000","journal-title":"nticancer Drugs"},{"key":"R2-54-20210202","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1097\/01.mjt.0000522273.81146.49","article-title":". Recurrent lower extremity pseudocellulitis.","volume":"19","author":"Korniyenko","year":"2012","journal-title":"Am J Ther"},{"key":"R3-54-20210202","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1468-3083.2002.00485.x","article-title":". Gemcitabine-induced erysipeloid skin lesions in a patient with malignant mesothelioma.","volume":"16","author":"Kuku","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R5-54-20210202","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1468-3083.2006.01535.x","article-title":"Erysipeloid skin toxicity induced by gemcitabine.","volume":"20","author":"Zustovich","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R6-54-20210202","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1086\/520684","article-title":". Gemcitabine-related pseudocellulitis: report of 2 cases and review of the literature.","volume":"45","author":"Tan","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R7-54-20210202","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1200\/JCO.1991.9.3.491","article-title":". A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.","volume":"9","author":"Abbruzzese","year":"1991","journal-title":"J Clin Oncol"},{"key":"R9-54-20210202","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/(SICI)1099-081X(199804)19:3<193::AID-BDD88>3.0.CO;2-V","article-title":"The effect of lymphatic oedema on the uptake of colloids to the lymph nodes.","volume":"19","author":"Hawley","year":"1998","journal-title":"Biopharm Drug Dispos"},{"key":"R10-54-20210202","first-page":"180","article-title":"Gemcitabine in the treatment of soft tissue sarcomas.","volume":"27","author":"Bauer","year":"2004","journal-title":"Onkologie"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MJT.0000000000000024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:24:08Z","timestamp":1620962648000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045391-201601000-00054"}},"subtitle":["A Case Report and Review of the Current Literature"],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0000000000000024","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}